hesperidin has been researched along with Liver Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hasanin, AH; Matboli, M; Seleem, HS | 1 |
| Eissa, LA; El-Karef, A; El-Shishtawy, MM; Elsherbiny, NM; Kenawy, HI; Zaghloul, RA | 1 |
| Ahamad, S; Alajmi, MF; Hassan, MI; Hussain, A; Luqman, S; Naz, H; Rehman, MT; Tarique, M | 1 |
| Gu, Y; Tao, L; Yang, JK; Zhao, AG; Zheng, J; Zhou, X; Zhu, YJ | 1 |
| Dong, W; Song, J; Wang, J; Wu, D; Zhang, J | 1 |
| Banjerdpongchai, R; Duangnil, N; Khaw-On, P; Kongtawelert, P; Rachakhom, W; Wudtiwai, B | 1 |
| Hong, GE; Kim, EH; Kim, GS; Lee, HJ; Lee, WS; Raha, S; Saralamma, VV; Yumnam, S | 1 |
| Abdulaal, WH; Bawazeer, NA; Choudhry, H; Middleton, B; Moselhy, SS; Zamzami, MA | 1 |
| Alonso-Moraga, A; Anter, J; Fernández-Bedmar, Z; Guil-Luna, S; Martín de Las Mulas, J; Millán-Ruiz, Y | 1 |
| Huang, YY; Hung, CM; Kao, ST; Lee, KH; Liu, CJ; Yeh, CC; Yeh, MH | 1 |
| Arai, N; Chaen, H; Kibata, M; Kubota, M; Mitsuzumi, H; Miwa, Y; Okada, K; Sunayama, T; Tanabe, F; Yamada, M | 1 |
11 other study(ies) available for hesperidin and Liver Neoplasms
| Article | Year |
|---|---|
Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats.
Topics: Animals; Hesperidin; Liver Neoplasms; Male; Neoplasm Proteins; Precancerous Conditions; rab GTP-Binding Proteins; Rats; Rats, Wistar; RNA, Neoplasm | 2020 |
Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways.
Topics: Animals; Carcinoma, Hepatocellular; Gene Expression Regulation; Hesperidin; Liver Neoplasms; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thioacetamide; Wnt Signaling Pathway; Wnt-5a Protein; Wnt3A Protein | 2017 |
Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells.
Topics: Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; HEK293 Cells; Hesperidin; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Neuroblastoma; Signal Transduction | 2019 |
Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Fluorouracil; HCT116 Cells; Hesperidin; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 7; Mice, Inbred BALB C; Mice, Nude; Rats; RNA, Messenger; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Calcium; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Cytoplasm; Hesperidin; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Reactive Oxygen Species; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways.
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Citrus; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hesperidin; Humans; Inhibitory Concentration 50; Liver Neoplasms; Mitochondria; Reactive Oxygen Species; Receptors, Death Domain | 2016 |
Mitochondrial Dysfunction and Ca(2+) Overload Contributes to Hesperidin Induced Paraptosis in Hepatoblastoma Cells, HepG2.
Topics: Antineoplastic Agents, Phytogenic; Calcium; Calcium Signaling; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Hep G2 Cells; Hepatoblastoma; Hesperidin; Humans; Inositol 1,4,5-Trisphosphate Receptors; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Swelling; Ryanodine Receptor Calcium Release Channel; Superoxides; Time Factors | 2016 |
Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells.
Topics: Gene Expression; Hep G2 Cells; Hesperidin; Humans; Liver Neoplasms; Receptors, LDL; Sterol Regulatory Element Binding Proteins | 2016 |
Demethylating and anti-hepatocarcinogenic potential of hesperidin, a natural polyphenol of Citrus juices.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Carcinoma, Hepatocellular; Cell Line, Tumor; Citrus; DNA Methylation; Fruit and Vegetable Juices; Hesperidin; Humans; Liver; Liver Neoplasms; Male; Rats, Sprague-Dawley | 2017 |
The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Hesperidin; Humans; I-kappa B Kinase; Liver Neoplasms; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; NF-kappa B; Protein Kinase C; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2010 |
Suppression of apolipoprotein B secretion from HepG2 cells by glucosyl hesperidin.
Topics: Analysis of Variance; Apolipoproteins B; Carcinoma, Hepatocellular; Cells, Cultured; Cholesterol Esters; Enzyme-Linked Immunosorbent Assay; Glucosides; Hesperidin; Humans; In Vitro Techniques; Lipoproteins, VLDL; Liver Neoplasms; Models, Biological; Time Factors; Triglycerides | 2006 |